Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
National Institute of Mental Health · GlaxoSmithKline (United Kingdom) · +27 more institutions
Indexed incrossrefpubmed
Abstract
An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.
Citation impact
1,979
total citations
- FWCI
- 72.76
- Percentile
- 100%
- References
- 13
Citations per year
Authors
30- RBRobert B. InnisCorresponding
National Institute of Mental Health
- VJVincent J. Cunningham
GlaxoSmithKline (United Kingdom), Imperial College London
- JDJacques Delforge
Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institut d'Imagerie Biomédicale
- MFMasahiro Fujita
National Institute of Mental Health
- AGAlbert Gjedde
Aarhus University
Topics & keywords
Topics
Keywords
- In vivo
- Nomenclature
- Chemistry
- Pharmacokinetics
- Medicine
- Pharmacology
- Medical physics
- Neuroscience
No related works found for this paper.